What Finland Figured Out About Diabetes Prevention and What We Can Learn

Written by Clare Koning RN PhD | April 2026

In 1993, Finland had one of the highest rates of type 2 diabetes in the world. Rather than funding another awareness campaign or launching another clinical pilot, its government made a different decision: it built a structured, evidence-based, community-delivered prevention program and ran it at scale across the country.

The Finnish Diabetes Prevention Study, one of the most cited randomized controlled trials in metabolic health research, published in the New England Journal of Medicine, demonstrated that intensive lifestyle intervention in people with impaired glucose tolerance reduced the incidence of type 2 diabetes by 58% over four years. Crucially, the effect held.

A 13-year follow-up published in Diabetologia showed that participants continued to have significantly lower diabetes incidence long after the structured intervention had ended. The behavioural and biological changes had embedded themselves.

Finland did not stop at the trial. It used the evidence to build a nationwide system of structured lifestyle counselling delivered through primary health care, the FIN-D2D program, training thousands of healthcare professionals, creating standardized screening tools, and building community infrastructure to reach people before they received a diagnosis. By the mid-2000s, Finland had meaningfully bent its diabetes incidence curve, not through a drug, not through a new technology, but through coordinated, evidence-grounded, population-level prevention.

The Trial Was a Proof Point. The Program Was the Point.

What distinguishes Finland's approach from patterns we see repeatedly in health systems like our own is not the quality of the science. Canada and BC have produced world-class evidence on diabetes prevention for decades. The distinction is in what happened after the evidence arrived.

In Finland, the evidence was treated as a mandate. It generated political commitment, system investment, training infrastructure, and an implementation architecture designed from the beginning to be permanent rather than provisional.

Elsewhere, including here, equivalent evidence has tended to generate publications, conference presentations, and pilot projects. What it has rarely generated is the coordinated, multi-year, multi-sector implementation that translates a 58% risk reduction in a trial into a 58% risk reduction in actual communities.

A 2025 investigation by the Digital Journal into Canada's health innovation landscape put it plainly: promising tools routinely prove their value in controlled settings but cannot navigate the barriers needed to reach patients at scale, leaving Canada's health system stuck in what researchers have described as "pilot limbo," with specialist wait times now reaching 30 weeks nationally.

England Took the Same Lesson and Built a System

Finland is not an isolated case. The NHS England Diabetes Prevention Program, launched in 2016, has become one of the largest evidence-based diabetes prevention efforts in the world. Early outcomes data published in Diabetes Care found that by late 2018 alone, over 324,000 people had been referred and 96,000 had attended at least one intervention session, with associated reductions in HbA1c and body weight.

A six-year independent evaluation published in Diabetic Medicine concluded that, despite the challenges of translating research into routine NHS delivery at scale, the program was more effective than usual care at reducing diabetes incidence, and generated actionable insights for continuous improvement along the way.

A key design feature was standardization: rather than leaving each clinical team to identify and refer high-risk individuals according to their own judgment, the program embedded systematic screening and referral into routine primary care workflow. NHS data show that people who completed the program had the lowest rate of progression to type 2 diabetes at 15.1%, compared to 21.2% among those referred but who did not attend, a meaningful real-world gap that systematic referral helps close.

Standardization is not the same as uniformity. The NHS model allows for cultural adaptation and local delivery variation. What it standardizes is the identification, the referral, and the core program components, the infrastructure, not the community experience of it.

We Have the Components. What We Lack Is the Connection.

BC already has many of the building blocks that made these international models work. Population health data through PHSA and health authority surveillance systems. Community delivery infrastructure through organizations like YMCA BC and Self Management BC. Clinical guidelines from Diabetes Canada that align closely with what the Finnish DPS demonstrated. Digital platforms capable of connecting high-risk individuals with community resources, including the T2D Network's digital platform built specifically for this purpose.

What has not happened is connecting these components into a systematic, province-wide prevention pathway, with standardized identification, consistent referral mechanisms, and structured follow-through that does not depend on the initiative of individual clinicians or the luck of living near a well-resourced urban center.

Diabetes Canada projects a 44% increase in BC's diabetes prevalence over the coming decade – the second largest projected increase among Canadian provinces. The cost of not building that pathway is already being calculated in hospital admissions, avoidable complications, and lost years of healthy life.

The coordination work that makes such a pathway conceivable is already underway. But coordination without policy commitment and sustained investment is not enough to replicate what Finland and England achieved. They bent their diabetes curves because their governments decided to. We have the evidence, the community infrastructure, and the provincial networks to make a similar decision.

The missing ingredient is not scientific. It is political will, and the system architecture to act on it.

The T2D Network is BC's provincial network for type 2 diabetes prevention, self-management, and remission, supported by IHSTS and previously Health Quality BC. Learn more at www.t2dnetwork.ca.